Literature DB >> 30023381

Aspirin and diabetes mellitus in primary prevention: the Endless Conundrum.

Rubén Casado-Arroyo1.   

Abstract

Entities:  

Year:  2018        PMID： 30023381      PMCID： PMC6035968          DOI： 10.21037/atm.2018.03.26

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  24 in total

1.  Type 2 Diabetes, Obesity, and Aspirin Responsiveness.

Authors:  Carlo Patrono; Bianca Rocca
Journal:  J Am Coll Cardiol       Date:  2017-01-11       Impact factor: 24.094

2.  Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1988-01-28       Impact factor: 91.245

3.  Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.

Authors: 
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

4.  Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.

Authors:  P Patrignani; P Filabozzi; C Patrono
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

5.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

6.  Randomised trial of prophylactic daily aspirin in British male doctors.

Authors:  R Peto; R Gray; R Collins; K Wheatley; C Hennekens; K Jamrozik; C Warlow; B Hafner; E Thompson; S Norton
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30

7.  Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Authors:  Peter M Rothwell; Michelle Wilson; Jacqueline F Price; Jill F F Belch; Tom W Meade; Ziyah Mehta
Journal:  Lancet       Date:  2012-03-21       Impact factor: 79.321

8.  Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin.

Authors:  Alfred A Bartolucci; Michal Tendera; George Howard
Journal:  Am J Cardiol       Date:  2011-04-08       Impact factor: 2.778

9.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

10.  The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

Authors:  Jill Belch; Angus MacCuish; Iain Campbell; Stuart Cobbe; Roy Taylor; Robin Prescott; Robert Lee; Jean Bancroft; Shirley MacEwan; James Shepherd; Peter Macfarlane; Andrew Morris; Roland Jung; Christopher Kelly; Alan Connacher; Norman Peden; Andrew Jamieson; David Matthews; Graeme Leese; John McKnight; Iain O'Brien; Colin Semple; John Petrie; Derek Gordon; Stuart Pringle; Ron MacWalter
Journal:  BMJ       Date:  2008-10-16
View more
  3 in total

Review 1.  Role of and Recent Evidence for Antiplatelet Therapy in Prevention of Cardiovascular Disease in Diabetes.

Authors:  Ajay Nair Sharma; Jacob S Deyell; Shay Nair Sharma; Ailin Barseghian
Journal:  Curr Cardiol Rep       Date:  2019-06-28       Impact factor: 2.931

2.  Molecular modeling and docking analysis of aspirin with pde7b in the context of neuro-inflammation.

Authors:  Arthi Balasundaram; Darling Chellathai David
Journal:  Bioinformation       Date:  2020-02-29

3.  UP Philippine General Hospital Division of Endocrinology, Diabetes & Metabolism Consensus Recommendations for In-Patient Management of Diabetes Mellitus among Persons with COVID-19.

Authors:  Cecilia Jimeno; Ma Cecille Anonuevo-Cruz; Angelique Bea Uy; Adrian Oscar Bacena; Mark David Francisco; Angelique Love Tiglao-Gica; Racquel Bruno; Diane Grace Corpuz
Journal:  J ASEAN Fed Endocr Soc       Date:  2020-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.